首页> 外文OA文献 >Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis
【2h】

Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis

机译:一氧化氮用于成人和儿童急性呼吸窘迫综合征和急性肺损伤:荟萃分析和试验序贯分析的系统评价

摘要

Acute hypoxemic respiratory failure, defined as acute lung injury and acute respiratory distress syndrome, are critical conditions associated with frequent mortality and morbidity in all ages. Inhaled nitric oxide (iNO) has been used to improve oxygenation, but its role remains controversial. We performed a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials (RCTs). We searched CENTRAL, Medline, Embase, International Web of Science, LILACS, the Chinese Biomedical Literature Database, and CINHAL (up to January 31, 2010). Additionally, we hand-searched reference lists, contacted authors and experts, and searched registers of ongoing trials. Two reviewers independently selected all parallel group RCTs comparing iNO with placebo or no intervention and extracted data related to study methods, interventions, outcomes, bias risk, and adverse events. All trials, irrespective of blinding or language status were included. Retrieved trials were evaluated with Cochrane methodology. Disagreements were resolved by discussion. Our primary outcome measure was all-cause mortality. We performed subgroup and sensitivity analyses to assess the effect of iNO in adults and children and on various clinical and physiological outcomes. We assessed the risk of bias through assessment of trial methodological components. We assessed the risk of random error by applying trial sequential analysis.
机译:急性低氧血症性呼吸衰竭被定义为急性肺损伤和急性呼吸窘迫综合征,是与所有年龄段的频繁死亡和发病率相关的关键疾病。吸入一氧化氮(iNO)已用于改善氧合作用,但其作用仍存在争议。我们对随机临床试验(RCT)进行了荟萃分析和试验顺序分析,进行了系统评价。我们搜索了CENTRAL,Medline,Embase,International Web of Science,LILACS,中国生物医学文献数据库和CINHAL(截至2010年1月31日)。此外,我们手动搜索了参考文献列表,联系的作者和专家,并搜索了正在进行的试验的注册资料。两名评价者独立选择所有平行组RCT,将iNO与安慰剂或不进行干预进行比较,并提取与研究方法,干预措施,结果,偏倚风险和不良事件相关的数据。包括所有试验,无论盲目的或语言状态如何。检索的试验采用Cochrane方法进行评估。分歧通过讨论得到解决。我们的主要结局指标是全因死亡率。我们进行了亚组和敏感性分析,以评估iNO对成人和儿童以及各种临床和生理结果的影响。我们通过评估试验方法的组成部分来评估偏倚的风险。我们通过应用试验顺序分析评估了随机错误的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号